Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » ELF and ERS urge the EU to better regulate novel tobacco products
In May 2023, ELF and ERS provided feedback to the EU consultation on tobacco control.
Last month, ELF and ERS answered the European Commission’s public consultation on the evaluation of legislative framework for tobacco control. Based on scientific research findings, ELF and ERS got the opportunity to once more voice their viewpoint on the risks of novel and emerging tobacco and nicotine products, as well as to propose a direction for future EU and national regulations.
When it comes to novel and emerging tobacco and nicotine products, ELF and ERS provided 7 reasons why they are not risk-free:
ELF and ERS proposed the following guidelines for future regulation:
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79